Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Lemonade Inc ha un obiettivo di prezzo di consenso pari a $33.75, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Piper Sandler, Morgan Stanley y Piper Sandler il octubre 10, 2025, octubre 7, 2025 y septiembre 17, 2025. Con un obiettivo di prezzo medio di $53.33 tra le Piper Sandler, Morgan Stanley y Piper Sandler, c'è un implicito 0.63% upside per Lemonade Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/10/2025 | 3.77% | Piper Sandler | $60 → $55 | Maintains | Neutral | |||
10/07/2025 | -15.09% | Morgan Stanley | $43 → $45 | Maintains | Underweight | |||
09/17/2025 | 13.21% | Piper Sandler | $55 → $60 | Maintains | Neutral | |||
08/18/2025 | -20.75% | BMO Capital | $23 → $42 | Maintains | Underperform | |||
08/14/2025 | 3.77% | Piper Sandler | → $55 | Assumes | → Neutral | |||
07/14/2025 | -50.94% | Morgan Stanley | $24 → $26 | Maintains | Underweight | |||
07/02/2025 | -56.6% | BMO Capital | $15 → $23 | Maintains | Underperform | |||
07/01/2025 | -50.94% | Keefe, Bruyette & Woods | $22 → $26 | Reiterates | Underperform → Underperform | |||
04/22/2025 | -58.49% | Keefe, Bruyette & Woods | $25 → $22 | Maintains | Underperform | |||
04/08/2025 | -54.72% | Morgan Stanley | $35 → $24 | Downgrade | Equal-Weight → Underweight | |||
02/26/2025 | -35.85% | Piper Sandler | $44 → $34 | Maintains | Neutral | |||
02/26/2025 | 13.21% | Citizens Capital Markets | $60 → $60 | Reiterates | Market Outperform → Market Outperform | |||
11/22/2024 | 13.21% | JMP Securities | $40 → $60 | Maintains | Market Outperform | |||
11/21/2024 | -71.7% | BMO Capital | $13 → $15 | Maintains | Underperform | |||
11/21/2024 | -16.98% | Piper Sandler | $25 → $44 | Maintains | Neutral | |||
11/20/2024 | -20.75% | Morgan Stanley | $23 → $42 | Upgrade | Underweight → Equal-Weight | |||
11/15/2024 | -56.6% | Morgan Stanley | $15 → $23 | Maintains | Underweight | |||
11/07/2024 | -60.38% | Keefe, Bruyette & Woods | $18 → $21 | Downgrade | Market Perform → Underperform | |||
11/01/2024 | -52.83% | Piper Sandler | $18 → $25 | Maintains | Neutral | |||
10/15/2024 | -24.53% | JMP Securities | $40 → $40 | Reiterates | Market Outperform → Market Outperform | |||
10/09/2024 | -73.58% | Jefferies | $15 → $14 | Maintains | Underperform | |||
05/07/2024 | -69.81% | Jefferies | $14 → $16 | Maintains | Underperform | |||
05/02/2024 | -66.04% | Piper Sandler | $17 → $18 | Maintains | Neutral | |||
04/15/2024 | -24.53% | JMP Securities | $40 → $40 | Reiterates | Market Outperform → Market Outperform | |||
03/04/2024 | -66.04% | Keefe, Bruyette & Woods | $16 → $18 | Maintains | Market Perform | |||
02/29/2024 | -67.92% | Piper Sandler | → $17 | Reiterates | Neutral → Neutral | |||
02/28/2024 | -73.58% | Morgan Stanley | $13 → $14 | Maintains | Underweight | |||
12/01/2023 | — | Oppenheimer | — | Downgrade | Outperform → Perform | |||
11/07/2023 | -77.36% | Morgan Stanley | $11 → $12 | Maintains | Underweight | |||
11/02/2023 | -79.25% | Morgan Stanley | $10 → $11 | Maintains | Underweight | |||
10/11/2023 | -81.13% | Morgan Stanley | $15 → $10 | Maintains | Underweight | |||
09/28/2023 | -83.02% | BMO Capital | $8 → $9 | Maintains | Underperform | |||
08/04/2023 | -67.92% | Piper Sandler | $18 → $17 | Maintains | Neutral | |||
08/03/2023 | -71.7% | Morgan Stanley | $14 → $15 | Maintains | Underweight | |||
07/12/2023 | -24.53% | JMP Securities | → $40 | Reiterates | Market Outperform → Market Outperform | |||
06/20/2023 | -73.58% | Morgan Stanley | → $14 | Initiates | → Underweight | |||
05/09/2023 | -67.92% | Barclays | $16 → $17 | Maintains | Equal-Weight | |||
05/05/2023 | -66.04% | Piper Sandler | → $18 | Reiterates | → Neutral | |||
05/04/2023 | -77.36% | B of A Securities | $14 → $12 | Maintains | Underperform | |||
05/04/2023 | -24.53% | JMP Securities | → $40 | Reiterates | → Market Outperform | |||
04/18/2023 | -24.53% | JMP Securities | → $40 | Reiterates | → Market Outperform | |||
04/10/2023 | -78.3% | Jefferies | $13 → $11.5 | Maintains | Underperform | |||
02/24/2023 | -69.81% | Barclays | $18 → $16 | Maintains | Equal-Weight | |||
02/24/2023 | -66.04% | Piper Sandler | $19 → $18 | Maintains | Neutral | |||
01/20/2023 | -81.13% | BMO Capital | → $10 | Initiates | → Underperform | |||
01/18/2023 | -64.15% | Piper Sandler | $20 → $19 | Maintains | Neutral | |||
11/17/2022 | -54.72% | Keefe, Bruyette & Woods | → $24 | Initiates | → Market Perform | |||
11/10/2022 | -66.04% | Barclays | $28 → $18 | Maintains | Equal-Weight | |||
11/10/2022 | -62.26% | Piper Sandler | $25 → $20 | Maintains | Neutral |
El último precio objetivo de Lemonade (NYSE:LMND) fue comunicado por Piper Sandler el octubre 10, 2025. La firma de analistas fijó un precio objetivo para $55.00 que espera LMND a rise dentro de 12 meses (un posible 3.77% upside). 19 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Lemonade (NYSE:LMND) fue proporcionada por Piper Sandler, y Lemonade mantuvo su neutral calificación.
La última revisión al alza de Lemonade Inc se produjo en noviembre 20, 2024, cuando Morgan Stanley elevó su precio objetivo a $42. Morgan Stanley anteriormente tenía an underweight para Lemonade Inc.
La última revisión a la baja de Lemonade Inc se produjo en abril 8, 2025, cuando Morgan Stanley cambió su precio objetivo de $35 a $24 para Lemonade Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Lemonade, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Lemonade se registró el octubre 10, 2025, por lo que la próxima calificación estará disponible en torno al octubre 10, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Lemonade (LMND) fue un mantuvo con un precio objetivo de $60.00 a $55.00. El precio actual al que cotiza Lemonade (LMND) es de $53.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.